Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Parents Appear Receptive to Children Receiving HPV Vaccine at 9 or 10 Years of Age

Clinicians consider administration of human papillomavirus (HPV) vaccine as feasible at age 9 to 10 years, and parents appear to be receptive to discussing vacc

Can A Vegan Diet Reduce Menopause Symptoms?

MONDAY, June 2, 2025 Hot flashes, night sweat and other symptoms making menopause hellish for you You might consider going vegan, a new study suggestsSevere hot

Wildfire Smoke Dents Survival Odds For Lung Cancer Patients

MONDAY, June 2, 2025 Wildfire smoke could make it harder for people with lung cancer to survive, a new study says.Californians with lung cancer who breathed smo

Fluoride Ban Could Create Cavities For 1 Of Every 3 U.S. Kids

MONDAY, June 2, 2025 Removing fluoride from the U.S. water supply could result in more than 25 million more decayed teeth in children and teenagers within five

Cancer Treatment 'Brain Drain' Occurring In Rural Areas

MONDAY, June 2, 2025 U.S. rural communities could be experiencing a brain drain when it comes to cancer care, a new study says.Most new radiation oncologists do

Eating Healthier Can Protect Aging Brain

MONDAY, June 2, 2025 It s never too late to start eating right as a means of protecting your brain health, a new study says.People who improved their healthy ea

How Caffeine Affects Your Brain While You Sleep

SUNDAY, June 1, 2025 Your morning cup of coffee might help you power through the day but could it be keeping your brain too alert at night, even while you sleep

Feeling Work Stress? Your Dog Might Be Feeling It Too

SATURDAY, May 31, 2025 Stress from work doesn t always stay at the office and it may be affecting more than just your mood. A new study finds that your dog may

Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis

Genentech, a member of the Roche Group (SIX RO, ROG OTCQX RHHBY), announced today new, 96-week data for fenebrutinib demonstrating that patients with relapsing

Itepekimab Met Primary Endpoint in One of Two Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Trials

Regeneron Pharmaceuticals, Inc. (NASDAQ REGN) and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use of itepekimab in adu

Popular Keywords